We are live on ! Find out more
BIOR

Biora Therapeutics, Inc. Common Stock
BIOR

Delisted

BIOR was delisted on the 10th of December, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Biora Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 20 → 0 (-20)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $6.13M → $0 (-$6.13M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 19

Holders
–
Holders Change
-20
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$350K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$78.4K
3
Morgan Stanley
Morgan Stanley
New York
-$72.7K
4
Northern Trust
Northern Trust
Illinois
-$34.4K
5
BlackRock
BlackRock
New York
-$30.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
– -$350K -69,733 Closed
Geode Capital Management
2
Geode Capital Management
Massachusetts
– -$78.4K -15,630 Closed
Morgan Stanley
3
Morgan Stanley
New York
– -$72.7K -14,503 Closed
Northern Trust
4
Northern Trust
Illinois
– -$34.4K -6,857 Closed
BlackRock
5
BlackRock
New York
– -$30.9K -6,161 Closed
State Street
6
State Street
Massachusetts
– -$25.9K -5,157 Closed
HF
7
HRT Financial
New York
– -$16K -3,380 Closed
XT
8
XTX Topco
Cayman Islands
– -$10.6K -2,117 Closed
LPL Financial
9
LPL Financial
California
– -$10.4K -2,070 Closed
TSS
10
Two Sigma Securities
New York
– -$8.42K -1,679 Closed
Barclays
11
Barclays
United Kingdom
– -$3.02K -601 Closed
Wells Fargo
12
Wells Fargo
California
– -$2.01K -400 Closed
Bank of America
13
Bank of America
North Carolina
– -$798 -159 Closed
TWC
14
TD Waterhouse Canada
Ontario, Canada
– -$550 -112 Closed
Osaic Holdings
15
Osaic Holdings
Arizona
– -$323 -65 Closed
RAM
16
Riggs Asset Management
Pennsylvania
– -$201 -40 Closed
SPIA
17
Steward Partners Investment Advisory
New York
– -$16 -3 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– -$11 -2 Closed
TAM
19
Tucker Asset Management
Colorado
– -$1 – –

BIOR Hedge Fund Activity: Q4 2024 in Review

0 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q4 2024, worth a combined $0 — down 100% from $6.13M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BIOR and 0 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $350K sold.

  • 0 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q4 2024, down from 20 in Q3 2024.
  • Funds reported $0 of Biora Therapeutics, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q4 2024 and 19 closed out, a net change of -19 holders.
  • The largest Biora Therapeutics, Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $350K sold.

Based on aggregated 13F filings for Q4 2024.